Teladoc Health, Inc., a prominent player in the health care technology sector, has been navigating a challenging financial landscape as of late 2025. Based in Purchase, United States, Teladoc Health specializes in delivering healthcare services via phone and video consultations, diagnosing routine medical issues, recommending treatments, and prescribing medications. The company serves a global patient base and is listed on the New York Stock Exchange.
As of December 25, 2025, Teladoc Health’s stock closed at $7.12. This price places the company approximately 52% below its 52-week high of $15.21, recorded on February 13, 2025, and 14% above its 52-week low of $6.35, observed on April 20, 2025. The stock’s recent closing price of $7.25, as of December 9, 2025, reflects a continued period of volatility and underscores the challenges faced by the company in maintaining its market position.
The company’s market capitalization stands at $1.29 billion USD, indicating its substantial presence in the health care technology industry. However, Teladoc Health’s financial metrics reveal areas of concern. The price-to-earnings (P/E) ratio is currently at -5.65, indicating negative earnings. This negative P/E ratio suggests that the company is not generating profits, which can be a red flag for investors seeking growth and stability.
Additionally, the price-to-book (P/B) ratio of 0.92 indicates that the company’s shares are trading below book value. This metric suggests that the market valuation of Teladoc Health is less than the net asset value of the company, which may reflect investor skepticism about the company’s future prospects.
Teladoc Health remains in a quiet period, with its most recent coverage announcement dated December 9, 2025. This period typically involves restrictions on public communications by the company, often in anticipation of significant financial disclosures or events.
Despite these challenges, Teladoc Health continues to leverage its expertise in telehealth services, a sector that has seen increased demand due to its convenience and accessibility. The company’s ability to adapt to changing market conditions and regulatory environments will be crucial in determining its future trajectory.
For more detailed information about Teladoc Health, Inc., stakeholders and interested parties can visit the company’s website at www.teladochealth.com . The company’s Initial Public Offering (IPO) took place on July 1, 2015, marking its entry into the public market and setting the stage for its growth and development in the health care technology sector.